Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples
Open Access
- 17 May 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (10), 2096-2104
- https://doi.org/10.1002/jmv.25986
Abstract
The micro‐neutralization assay is a fundamental test in virology, immunology, vaccine assessment and epidemiology studies. Since the SARS‐CoV‐2 outbreak at the end of December 2019 in China, it has become extremely important to have well‐established and validated diagnostic and serological assays for this new emerging virus. Here, we present a micro‐neutralization assay with the use of SARS‐CoV‐2 wild type virus with two different methods of read‐out. We evaluated the performance of this assay using human serum samples taken from an italian seroepidemiological study being performed at the University of Siena, along with the human monoclonal antibody CR3022 and some iper‐immune animal serum samples against Influenza and Adenovirus strains. The same panel of human samples have been previously tested in ELISA as a pre‐screening. Positive, borderline and negative ELISA samples were evaluated in neutralization assay using two different method of read‐out: subjective (by means of an inverted optical microscope) and objective (by means of a spectrophotometer). Our findings suggest that at least 50% of positive ELISA samples are positive in neutralization as well, and that method is able to quantify different antibody concentrations in a specific manner. Taken together, our results confirm that the colorimetric cytopathic effect‐based microneutralization assay could be used as a valid clinical test method for epidemiological and vaccines studies.Keywords
This publication has 26 references indexed in Scilit:
- Comparison of lentiviruses pseudotyped with S proteins from coronaviruses and cell tropisms of porcine coronavirusesVirologica Sinica, 2016
- Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013Eurosurveillance, 2013
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaThe New England Journal of Medicine, 2012
- Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion CompetenceViruses, 2012
- Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in PsoriasisPLOS ONE, 2012
- Lipid rafts are involved in SARS-CoV entry into Vero E6 cellsBiochemical and Biophysical Research Communications, 2008
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging InfectionClinical Microbiology Reviews, 2007
- Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape MutantsPLoS Medicine, 2006
- SARS–associated Coronavirus Replication in Cell LinesEmerging Infectious Diseases, 2006
- Vitalfärbung von Lysosomen und anderen Zellorganellen der Ratte mit Neutralrot Vital Staining of Lysosomes and Other Cell Organelles of the Rat with Neutral RedProgress in Histochemistry and Cytochemistry, 1974